January 30, 2026 Posted by: Categories: No Comments The European Medicines Agency (EMA) published updated information on several medicines: Kisqali | European Medicines Agency (EMA) Seebri Breezhaler | European Medicines Agency (EMA) Exelon | European Medicines Agency (EMA) Enurev Breezhaler | European Medicines Agency (EMA) Tovanor Breezhaler | European Medicines Agency (EMA) Recarbrio | European Medicines Agency (EMA) Wainzua | European Medicines Agency (EMA) Leqvio | European Medicines Agency (EMA) Avastin | European Medicines Agency (EMA) Cetrotide | European Medicines Agency (EMA) Constella | European Medicines Agency (EMA) Rybelsus | European Medicines Agency (EMA) Ozempic | European Medicines Agency (EMA) Beovu | European Medicines Agency (EMA) Genvoya | European Medicines Agency (EMA) Zavesca | European Medicines Agency (EMA) Zirabev | European Medicines Agency (EMA) Koselugo | European Medicines Agency (EMA) Biktarvy | European Medicines Agency (EMA) Erbitux | European Medicines Agency (EMA) Saphnelo | European Medicines Agency (EMA) Insulin lispro Sanofi | European Medicines Agency (EMA) Zykadia | European Medicines Agency (EMA)
